Abstract
Despite scientific advances, procedures involving the allogeneic hematopoietic stem cell transplantation or gene editing that have emerged as a curative strategy in the last years, sickle cell disease (SCD) still remains one of the most prevalent genetic hematological diseases in the world. Difficulties related to curative approaches, such as cost and risk of procedures, are still barrier…